CT45A1 and cancer: Overall, the survival advantage of CT45A1‐expressing MSI‐H CRC cells during NK cell killing may not be a result of decreased activity of NK cells, highlighting that CT45A1 is a cancer‐autologous driver of NK cell resistance.